Science Explorer Interactive view Map
Company · Macquarie Park · Australia

Teva Pharmaceuticals (Australia)

tevapharm.comROR OpenAlex
Research works
29
▲ 302% vs 2013–17
Citations
363
12.6 per fractional work
Top-10% rate
6.0%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: Teva Pharmaceuticals (Australia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.71× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 4.32× its world share, 0 worksImmunology and Micro…Neuroscience: 5.67× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.00× its world share, 0 worksPharmacology, Toxico…Engineering: 0.09× its world share, 0 worksEngineeringEnvironmental Science: 0.60× its world share, 0 worksEnvironmental ScienceMedicine: 2.70× its world share, 4 worksMedicineNursing: 4.05× its world share, 0 worksNursingEconomics, Econometrics and Finance: 5.91× its world share, 1 worksEconomics, Econometr…Psychology: 0.86× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.0×. Every wedge is a field page.

Which keywords describe research at Teva Pharmaceuticals (Australia)?

By fractional works in all years, weighted toward what it does more of than the world: Neurological Disorders, Headache Disorders, Migraine, Epidemiology, Quality of Life, Treatment, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 12 words, with their numbers
  1. Neurological Disorders5▲ 24×9 topics
  2. Headache Disorders4▲ 516×1 topic
  3. Migraine4▲ 282×1 topic
  4. Epidemiology3▲ 2.6×19 topics
  5. Inflammation2▲ 2.8×11 topics
  6. Quality of Life2▲ 5.0×5 topics
  7. Treatment2▲ 4.6×11 topics
  8. Cost-effectiveness Analysis1▲ 58×1 topic
  9. Health Utility Measures1▲ 58×1 topic
  10. Clinical Trials1▲ 6.1×8 topics
  11. Monoclonal Antibodies1▲ 26×2 topics
  12. Oxidative Stress1▲ 1.98×10 topics

Which research topics does Teva Pharmaceuticals (Australia) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Migraine and Headache Studies, Genetic Neurodegenerative Diseases and Monoclonal and Polyclonal Antibodies Research.

Health Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksMigraine and Headache Studies: 1 fractional worksGenetic Neurodegenerative Diseases: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksMultiple Sclerosis Research Studies: 0 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional worksOphthalmology and Visual Impairment Studies: 0 fractional worksNeurological disorders and treatments: 0 fractional worksFibromyalgia and Chronic Fatigue Syndrome Research: 0 fractional works
Economics and EconometricsPsychiatry and Mental healthCellular and Molecular NeuroscienceRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Migraine and Headache Studies Psychiatry and Mental health 1 works
  3. 3 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
  6. 6 Peptidase Inhibition and Analysis Oncology 0 works
  7. 7 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
  9. 9 Neurological disorders and treatments Neurology 0 works
  10. 10 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.6%not open57.4%

World: 28% of research is openly available.

with international co-authors70.5%domestic only29.5%

World: 19% is written across borders.

How has Teva Pharmaceuticals (Australia)'s research output changed?

Output in 2018–2022 was 302% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Macquarie Park

All research institutions in Macquarie Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.